[Long term therapy of nephrotic syndrome and chronic glomerulonephritis in childhood].
D001323:Autoantibodies; D001327:Autoimmune Diseases; D001379:Azathioprine / Q000627:therapeutic use; D001485:Basement Membrane; D001665:Binding Sites; D002648:Child; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008134:Long-Term Care; D009402:Nephrosis, Lipoid / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology
D001323:Autoantibodies; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003520:Cyclophosphamide; D001379:Azathioprine
Langzeitbehandlung nephrotischer Syndrome und chronischer Glomerulonephritiden im Kindesalter.